98%
921
2 minutes
20
Repair of covalent DNA-protein crosslinks (DPCs) by DNA-dependent proteases has emerged as an essential genome maintenance mechanism required for cellular viability and tumor suppression. However, how proteolysis is restricted to the crosslinked protein while leaving surrounding chromatin proteins unharmed has remained unknown. Using defined DPC model substrates, we show that the DPC protease SPRTN displays strict DNA structure-specific activity. Strikingly, SPRTN cleaves DPCs at or in direct proximity to disruptions within double-stranded DNA. In contrast, proteins crosslinked to intact double- or single-stranded DNA are not cleaved by SPRTN. NMR spectroscopy data suggest that specificity is not merely affinity-driven but achieved through a flexible bipartite strategy based on two DNA binding interfaces recognizing distinct structural features. This couples DNA context to activation of the enzyme, tightly confining SPRTN's action to biologically relevant scenarios.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534798 | PMC |
http://dx.doi.org/10.1016/j.molcel.2020.08.003 | DOI Listing |
Lab Invest
September 2025
Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA. Electronic address:
Sinonasal mucosal melanoma (SNMM) is a rare aggressive malignancy of the sinonasal tract. Due to its advanced clinical presentation and frequent late-stage diagnosis, the 5-year survival rate is less than 30%, with an even worse prognosis in patients with distant metastasis (SNMM-M). Therefore, characterizing the molecular landscape of SNMM may provide novel therapeutic targets for SNMM-M.
View Article and Find Full Text PDFBiochemistry
September 2025
Department of Chemistry, Oakland University, Rochester, Michigan 48309, United States.
BRCA1 is a crucial component of homologous recombination (HR), a high-fidelity pathway for repairing double-stranded DNA breaks (DSBs) in human cells. The central region of the BRCA1 protein contains two putative DNA binding domains (DBDs), yet their relative substrate specificities and functional contributions to HR remain unclear. Here, we characterized the DNA binding properties of DBD1 (amino acids 330-554), DBD2 (amino acids 894-1057), and BRCA1 C-terminal (BRCT) repeats using biolayer interferometry.
View Article and Find Full Text PDFCancer Biol Ther
December 2025
Department of Urology, The First People's Hospital of Yuexi County, Liangshan Prefecture, China.
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) remains a significant therapeutic challenge and a leading cause of cancer-related mortality in men. PARP inhibitors like Olaparib are effective in homologous recombination repair (HRR)-deficient tumors, but resistance often arises through DNA repair restoration. This study explores the role of the structure-specific endonuclease subunit SLX1, a catalytic subunit of the SLX1-SLX4 endonuclease complex, in Olaparib resistance.
View Article and Find Full Text PDFTalanta
July 2025
Department of Biologics, Gachon University, 191 Hambakmoero, Yeonsu-gu, Incheon, Republic of Korea. Electronic address:
A novel one-step nucleic acid detection platform termed FACER (FEN1-assisted Cascade Enzymatic Reaction) has been developed, leveraging the structure-specific cleavage ability of the flap endonuclease (FEN1) enzyme for the sensitive detection of target DNA. FACER employs two specifically designed probes that hybridize with target DNA, forming a UP single flap structure cleaved by FEN1 to release adenosine monophosphate (AMP). The AMP serves as a substrate in a cascade enzymatic reaction (CER) involving myokinase, pyruvate kinase, and hexokinase, ultimately resulting in a decrease in glucose concentration measurable using a personal glucose meter (PGM).
View Article and Find Full Text PDFTalanta
July 2025
Hubei Key Laboratory of Pollutant Analysis & Reuse Technology, College of Chemistry and Chemical Engineering, Hubei Normal University, Huangshi, 435002, Hubei, China. Electronic address:
Flap endonuclease 1 (FEN1), a structure-specific nuclease, is usually overexpressed in various types of cancer cells and has been recognized as a promising biomarker for molecular diagnostics. In this work, we developed a one-tube and ultrasensitive method for FEN1 sensing based on customized target recognition, exponential signal amplification and nano-signal transduction. Due to rational palindrome design, only two DNA substrates and a pair of enzymes were needed in the sensing.
View Article and Find Full Text PDF